Mannan binding lectin in febrile adults: No correlation with microbial infection and complement activation

Journal of Clinical Pathology

Volumn 56, Issue 12, 2003, Pages 956-959

  Tacx, A N ^a   Groeneveld, A B J ^a   Hart, M H ^b   Aarden, L A ^b   Hack, C E ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; MANNAN BINDING LECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; BACTERIUM CULTURE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FEVER; HOST RESISTANCE; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; COMPLEMENT C3A; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; CROSS INFECTION; FEMALE; FEVER; HUMANS; INFECTION; MALE; MANNOSE-BINDING LECTIN; MIDDLE AGED;

EID: 0348041934     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.56.12.956     Document Type: Article

References (12)

1. Turner MW, Hamvas RMJ. Mannose-binding lectin: structure, function, genetics and disease associations. Rev Immunogenet 2000;2:305-22.
2. Petersen SV, Thiel S, Jensenius JC. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001;38:133-49.
3. Summerfield JA, Ryder S, Sumiya M, et al. Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1995;345:886-9.
4. Summerfield JA, Sumiya M, Levin M, et al. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br Med J 1997;314:1229-32.
5. Neth O, Hann I, Turner MW, et al. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet 2001;358:614-18.
6. Peterslund NA, Koch C, Jensenius JC, et al. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet 2001;358:637-8.
7. Roy S, Segal S, Griffiths D, et al. MBL genotype and risk of invasive pneumococcal disease: a case-control study. Lancet 2002;359:1569-73.
8. Mullighan CG, Heatley S, Doherty K, et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood 2002;99:3524-9.
9. Groeneveld ABJ, Bossink AWJ, Van Mierlo GJ, et al. Circulating inflammatory mediators in patients with fever: predicting bloodstream infection. Clin Diagn Lab Immunol 2001;8:1189-95.
10. Crosdale DJ, Ollier WER, Thomson W, et al. Mannose binding lectin (MBL) genotype distributions with relation to serum levels in UK Caucasoids. Eur J Immunogen 2000;27:111-17.
11. Kronborg G, Weis N, Madsen HO, et al. Variant mannose-binding lectin alleles are not associated with susceptibility to or outcome of invasive pneumococcal infection in randomly included patients. J Infect Dis 2002;185:1517-20.
12. 2-macroglobulin. J Immunol 2002;168:4078-86.